Photo
May 13, 2022
Faheem Hasnain
Chairman
Aspen Neuroscience
Stories this photo appears in:
Aspen Neuroscience Raises $147.5M in Series B Round
BIOTECH: Starting Clinical Trial for Parkinson’s Stem Cell Therapy
San Diego-based Aspen Neuroscience, Inc. announced a Series B financing round of $147.5 million on May 9 to further advance its treatment of Parkinson’s disease using autologous stem cell therapies.